Viscotek has been a strong advocate of good chromatography as a prerequisite for GPC (Gel Permeation Chromatography) data accuracy. Our recent work in application development has been driven by extremely difficult samples from industrial, biopharmaceutical, and academic sources. These samples present challenges ranging from sample solubility, column adsorption as well as detection issues. This report will attempt to highlight a new approach that could be very helpful in certain advanced GPC applications.
Viscotek has been a strong advocate of good chromatography as a prerequisite for GPC (Gel Permeation Chromatography) data accuracy. Our recent work in application development has been driven by extremely difficult samples from industrial, biopharmaceutical, and academic sources. These samples present challenges ranging from sample solubility, column adsorption as well as detection issues. This report will attempt to highlight a new approach that could be very helpful in certain advanced GPC applications.
Figure 1
Traditionally, the dissolution (sample) solvent and the mobile phase are one and the same in GPC. However, a closer look at the demands of sample solvent and mobile phase suggests that this should not always be the case. For the sample solvent one simply wants a solvent that quickly and completely dissolves the sample. Cost and chemical structure are secondary issues. For the mobile phase the requirements are significantly different:
Most low RI solvents, such as acetone and methanol for example, are weak or non-solvents for mid-to-low polarity polymers. But they will often support the solubility if the sample is dissolved in a stronger solvent and then diluted or injected into the weaker mobile phase solvent. We call this type of analysis Solvent Enhanced Light Scattering GPC.
The chromatogram shows a typical SELS example. A particular Fluoro-Polyester is quite soluble in THF, but the dn/dc is very low in THF. We would like to increase the dn/dc value to get better LS response. We could achieve that in a low refractive index solvent like Acetone.
However, the sample is not soluble in Acetone. But by dissolving the sample in THF and injecting the solution into a mobile phase of Acetone (SELS concept), we were able to maximize the accuracy and the reliability of the GPC-LS analysis while consuming one of the cheapest and safest solvents available.
Viscotek Corporation
15600 West Hardy Road, Houston, TX 77060
tel. (281) 445-5966, fax (281) 931-4336
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.